← FDA DRUG APPROVALS

FDA ANDA · ANDA083244

NEMBUTAL

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA083244
TYPE
ANDA
ORIGINAL APPROVAL
1975-01-08
LATEST ACTION
1995-09-20
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Discontinued

Products

NEMBUTALDiscontinued
PENTOBARBITAL 18.2MG/5ML · ELIXIR · ORAL

Approval history

1995-09-20Labeling · Supplement 10AP
1989-01-31Manufacturing (CMC) · Supplement 9AP
1984-03-30Manufacturing (CMC) · Supplement 6AP
1975-01-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →